United Kingdom  

Mass study into effect of anti-malaria drug on Covid-19 to continue

Hull Daily Mail Tuesday, 30 June 2020
More than 40,000 healthcare workers worldwide will be given chloroquine, hydroxychloroquine or a placebo in new global trial.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Meditation may help lower cardiovascular risk, study explains [Video]

Meditation may help lower cardiovascular risk, study explains

Mediation is known for its several benefits. According to a recent study, meditation may also help in cardiovascular risk reduction. By using a large national database with many participants, the..

Credit: ANI     Duration: 01:10Published
Scientists discover protective Alzheimer's gene, develop rapid drug-testing platform [Video]

Scientists discover protective Alzheimer's gene, develop rapid drug-testing platform

In breakthrough research, a gene has been discovered that can naturally suppress the signs of Alzheimer's disease in human brain cells. The scientists have also developed a new rapid drug-screening..

Credit: ANI     Duration: 01:25Published

Related news from verified sources

Mass study into effect of anti-malaria drug on Covid-19 given go-ahead

Mass study into effect of anti-malaria drug on Covid-19 given go-ahead
More than 40,000 healthcare workers worldwide will be given chloroquine, hydroxychloroquine or a placebo in new global trial
Wales Online


Tweets about this